Engineered T Cells Targeting Hepatitis B Antigen Show Glimmer of Benefit in Advanced Liver Cancer
A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...
A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...
A nationwide survey of 120 Chinese physicians reveals that most patients with advanced biliary tract cancer never receive guideline-recommended immunotherapy ...
A head-to-head trial of two fluorine-18 PD-L1 PET tracers in advanced lung cancer found equal tumor uptake between the agents ...
A new review in the Journal of Ovarian Research details how chronic inflammatory signaling pathways drive ovarian cancer progression and ...
University of Washington researchers have built a decision support system that combines PET imaging, immune repertoire sequencing, and blood cytokines ...
A new review details how hydrogel-based 3D platforms are transforming cancer research by recreating the tumor microenvironment for drug testing, ...
A case report describes a teenager who made a favorable neurological recovery after more than two weeks of super-refractory status ...
Highlighted studies at the 2026 ASTRO Annual Meeting in Boston span hypofractionated radiotherapy trials, proton versus photon therapy for liver ...
A sweeping review charts how CAR-T cell therapy has evolved from a blood cancer breakthrough into a versatile platform tackling ...
A sweeping 2024–2025 evidence review shows immune checkpoint inhibitors, frailty-adapted surgery, and artificial intelligence converging to transform esophageal cancer treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine